Sponsor Pipeline

AC Immune SA Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06015841 A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of… Parkinson Disease Active, Not Recruiting
Phase 1/2
NCT05462106 A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome… Amyloid Plaque Recruiting
Phase 1
NCT07463196 A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune… Healthy Participants Recruiting
Early Phase 1
NCT06891716 [18F]ACI-19626 PET in TDP-43 Proteinopathies Frontotemporal Dementia (FTD) Recruiting
NCT06891703 [18F]ACI-15916 PET in α-synucleinopathies Parkinson's Disease (PD) Recruiting
Disease Areas
Alzheimer's Disease (2) Parkinson's Disease (2) Dementia (2) ALS (1)
Get alerts when AC Immune SA's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free